{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:58:47Z","timestamp":1781557127057,"version":"3.54.5"},"reference-count":78,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T00:00:00Z","timestamp":1329868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0030975","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T22:09:44Z","timestamp":1329948584000},"page":"e30975","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Hemodialysis Removes Uremic Toxins That Alter the Biological Actions of Endothelial Cells"],"prefix":"10.1371","volume":"7","author":[{"given":"Kalliopi","family":"Zafeiropoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Bita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Polykratis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Karabina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vlachojannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Katsoris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0024-3205(94)00741-1","article-title":"NG-nitro-L-arginine-resistant endothelium-dependent relaxation induced by acetylcholine in the rabbit renal artery.","volume":"55","author":"S Kitagawa","year":"1994","journal-title":"Life Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/01.HYP.0000118053.42262.71","article-title":"Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo.","volume":"43","author":"H Matsuda","year":"2004","journal-title":"Hypertension"},{"key":"ref3","first-page":"1","article-title":"Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme.","volume":"3","author":"LM Ruilope","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000106103","article-title":"Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients.","volume":"25","author":"G Sahin","year":"2007","journal-title":"Blood Purif"},{"key":"ref5","first-page":"2223","article-title":"Structure and functions of the endothelium.","volume":"47","author":"O Chappey","year":"1997","journal-title":"Rev Prat"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"200P","DOI":"10.1016\/S0021-5198(19)59914-0","article-title":"The regulatory functions of the endothelium.","volume":"58","author":"EE Anggard","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00227892","article-title":"Paracrine functions of the coronary vascular endothelium.","volume":"157","author":"I Fleming","year":"1996","journal-title":"Mol Cell Biochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00019501-200109000-00007","article-title":"Functions of the healthy endothelium.","volume":"12","author":"RK Kharbanda","year":"2001","journal-title":"Coron Artery Dis"},{"key":"ref9","first-page":"79","article-title":"Metabolic functions of the pulmonary vascular endothelium.","volume":"26","author":"JW Ryan","year":"1982","journal-title":"Adv Vet Sci Comp Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01270584","article-title":"Regulatory functions of the coronary endothelium.","volume":"116","author":"VW van Hinsbergh","year":"1992","journal-title":"Mol Cell Biochem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM199007053230106","article-title":"Regulatory functions of the vascular endothelium.","volume":"323","author":"JR Vane","year":"1990","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00004872-199917050-00004","article-title":"Relationship between hypercholesterolaemia, endothelial dysfunction and hypertension.","volume":"17","author":"H Hayakawa","year":"1999","journal-title":"J Hypertens"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0002-9149(01)02064-1","article-title":"Effect of hyperhomocysteinemia on endothelial activation and dysfunction in patients with end-stage renal disease.","volume":"88","author":"M Ishikawa","year":"2001","journal-title":"Am J Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/ndt\/14.8.1934","article-title":"Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?","volume":"14","author":"K Kunz","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00001721-199410000-00006","article-title":"Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.","volume":"5","author":"M Takagi","year":"1994","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archinte.1974.00320180177015","article-title":"Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy.","volume":"133","author":"JM Lazarus","year":"1974","journal-title":"Arch Intern Med"},{"key":"ref17","first-page":"288","article-title":"Correlation of serum parathormone with hypertension in chronic renal failure patients treated with hemodialysis.","volume":"16","author":"A Baradaran","year":"2005","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000046673","article-title":"Correlation between soluble markers of endothelial dysfunction in patients with renal failure.","volume":"22","author":"SH Jacobson","year":"2002","journal-title":"Am J Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.0954-6820.1976.tb08228.x","article-title":"Hypertension in end-stage renal disease. The relationship between blood pressure, plasma renin, plasma renin substrate and exchangeable sodium in chronic hemodialysis patients.","volume":"200","author":"HJ Kornerup","year":"1976","journal-title":"Acta Med Scand"},{"key":"ref20","first-page":"17","article-title":"Arterial hypertension in children with end-stage renal failure treated with hemodialysis.","volume":"18","author":"M Szczepanska","year":"2005","journal-title":"Pol Merkur Lekarski"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI107470","article-title":"Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.","volume":"52","author":"EA Jaffe","year":"1973","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"22454","DOI":"10.1074\/jbc.M414407200","article-title":"Characterization of heparin affin regulatory peptide signaling in human endothelial cells.","volume":"280","author":"A Polykratis","year":"2005","journal-title":"J Biol Chem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.","volume":"65","author":"T Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1440-1746.2004.03344.x","article-title":"Correlation between plasma levels of matrix metalloproteinase (MMP)-9\/MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.","volume":"19","author":"TW Chung","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"P Libby","year":"2002","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"F1140","DOI":"10.1152\/ajprenal.00329.2001","article-title":"Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells.","volume":"282","author":"SV Brodsky","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/01.RES.79.5.1031","article-title":"Role of endothelium-related mechanisms in the pathophysiology of renal ischemia\/reperfusion in normal rabbits.","volume":"79","author":"C Caramelo","year":"1996","journal-title":"Circ Res"},{"key":"ref28","first-page":"381","article-title":"Oxidative stress and endothelial dysfunction in chronic kidney disease.","volume":"92","author":"V Costa-Hong","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1159\/000063552","article-title":"Endothelial dysfunction in uraemia.","volume":"20","author":"J Cross","year":"2002","journal-title":"Blood Purif"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1016\/j.transproceed.2009.07.080","article-title":"Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.","volume":"41","author":"A Karbowska","year":"2009","journal-title":"Transplant Proc"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1046\/j.1523-1755.63.s84.2.x","article-title":"Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease.","volume":"Suppl","author":"M Annuk","year":"2003","journal-title":"Kidney Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/ndt\/16.6.1189","article-title":"Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.","volume":"16","author":"CH Bolton","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"ref33","first-page":"300","article-title":"Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF.","volume":"26","author":"RJ Guerra","year":"1989","journal-title":"Blood Vessels"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2215\/CJN.04291007","article-title":"Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.","volume":"3","author":"E Linden","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1681\/ASN.2005121345","article-title":"Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension.","volume":"17","author":"C Zoccali","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00125-009-1263-5","article-title":"Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.","volume":"52","author":"JW Nin","year":"2009","journal-title":"Diabetologia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1524-475X.2010.00595.x","article-title":"Use of the parabiotic model in studies of cutaneous wound healing to define the participation of circulating cells.","volume":"18","author":"G Song","year":"2010","journal-title":"Wound Repair Regen"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1523-1755.2002.00423.x","article-title":"Advanced glycation end products and mortality in hemodialysis patients.","volume":"62","author":"SB Schwedler","year":"2002","journal-title":"Kidney Int"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"H1612","DOI":"10.1152\/ajpheart.00992.2002","article-title":"TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.","volume":"284","author":"H Chen","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.clinbiochem.2008.08.081","article-title":"Association of MMP-3 5A\/6A gene polymorphism with susceptibility to carotid atherosclerosis.","volume":"41","author":"T Djuric","year":"2008","journal-title":"Clin Biochem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"H1229","DOI":"10.1152\/ajpheart.00207.2003","article-title":"Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.","volume":"285","author":"S Hayashidani","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejheart.2007.12.009","article-title":"Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.","volume":"10","author":"D Kelly","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1016\/j.biomaterials.2011.04.031","article-title":"Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM.","volume":"32","author":"WY Lee","year":"2011","journal-title":"Biomaterials"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-8-50","article-title":"MMP-1 serum levels predict coronary atherosclerosis in humans.","volume":"8","author":"M Lehrke","year":"2009","journal-title":"Cardiovasc Diabetol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/B:HREV.0000011390.44039.b7","article-title":"MMP induction and inhibition in myocardial infarction.","volume":"9","author":"ML Lindsey","year":"2004","journal-title":"Heart Fail Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1172\/JCI22304","article-title":"Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.","volume":"115","author":"S Matsumura","year":"2005","journal-title":"J Clin Invest"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"H1858","DOI":"10.1152\/ajpheart.00216.2005","article-title":"Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy.","volume":"289","author":"H Matsusaka","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref48","first-page":"2864","article-title":"MMP inhibition and the development of cerebrovascular atherosclerosis: The road ahead.","volume":"33","author":"C Napoli","year":"2002","journal-title":"Stroke"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-3083.2010.02418.x","article-title":"Elevated MMP-8 and decreased myeloperoxidase concentrations associate significantly with the risk for peripheral atherosclerosis disease and abdominal aortic aneurysm.","volume":"72","author":"P Pradhan-Palikhe","year":"2010","journal-title":"Scand J Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.108.169623","article-title":"Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.","volume":"29","author":"C Tarin","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1517\/14728220802551140","article-title":"A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration.","volume":"12","author":"S Wakatsuki","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1097\/01.hjh.0000191245.68443.24","article-title":"Serum tissue inhibitors of metalloproteinases 1 (TIMP-1) and carotid atherosclerosis and aortic arterial stiffness.","volume":"23","author":"M Zureik","year":"2005","journal-title":"J Hypertens"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/01.ATV.0000197795.56960.64","article-title":"Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis.","volume":"26","author":"R de Nooijer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref54","first-page":"184","article-title":"Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes.","volume":"12","author":"B Florys","year":"2006","journal-title":"Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/jcb.21192","article-title":"Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells.","volume":"101","author":"FM Ho","year":"2007","journal-title":"J Cell Biochem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/01.CIR.0000121728.14930.DE","article-title":"Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.","volume":"109","author":"A Luttun","year":"2004","journal-title":"Circulation"},{"key":"ref57","first-page":"405","article-title":"Effects of TIMP-2 gene transfer on atherosclerotic plaque in rabbits.","volume":"33","author":"CQ Wang","year":"2005","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.atherosclerosis.2009.08.018","article-title":"Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women.","volume":"208","author":"BJ Jefferis","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"H1012","DOI":"10.1152\/ajpheart.00246.2010","article-title":"Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.","volume":"299","author":"V Kandalam","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/CIRCRESAHA.109.209189","article-title":"TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.","volume":"106","author":"V Kandalam","year":"2010","journal-title":"Circ Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/HJR.0b013e3283213108","article-title":"Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.","volume":"16","author":"J Hansson","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)64541-5","article-title":"Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome.","volume":"157","author":"KL Andrews","year":"2000","journal-title":"Am J Pathol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12192-010-0214-x","article-title":"Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment.","volume":"16","author":"K Musial","year":"2011","journal-title":"Cell Stress Chaperones"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.clinbiochem.2011.03.143","article-title":"Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis.","volume":"44","author":"K Pawlak","year":"2011","journal-title":"Clin Biochem"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ki.1996.10","article-title":"Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han:SPRD rat.","volume":"49","author":"L Schaefer","year":"1996","journal-title":"Kidney Int"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1139\/y05-011","article-title":"Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli.","volume":"83","author":"A Caron","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1096\/fj.06-5898fje","article-title":"Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury.","volume":"20","author":"S Cheng","year":"2006","journal-title":"FASEB J"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000058345","article-title":"Matrix metalloproteinases and their inhibitions in experimental renal scarring.","volume":"10","author":"TS Johnson","year":"2002","journal-title":"Exp Nephrol"},{"key":"ref69","first-page":"852","article-title":"Vascular immune reactions in arteritis and atherosclerosis. Receptors for endothelial adhesion.","volume":"94","author":"G Hansson","year":"1997","journal-title":"Lakartidningen"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.0954-6820.1987.tb09897.x","article-title":"Endothelial dysfunction and injury in atherosclerosis.","volume":"Suppl 715","author":"GK Hansson","year":"1987","journal-title":"Acta Med Scand"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbadis.2004.01.002","article-title":"Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis.","volume":"1689","author":"JA Maier","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref72","first-page":"151","article-title":"Endothelial dysfunction, atherosclerosis and thrombosis in uremia\u2013possibilities of intervention.","volume":"49","author":"M Mysliwiec","year":"2004","journal-title":"Rocz Akad Med Bialymst"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword.","volume":"6","author":"GK Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/3-540-36028-X_9","article-title":"Vascular endothelium and atherosclerosis.","volume":"176 Pt 2","author":"P Libby","year":"2006","journal-title":"Handb Exp Pharmacol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cmet.2008.08.016","article-title":"Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis.","volume":"8","author":"R Gareus","year":"2008","journal-title":"Cell Metab"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1194\/jlr.R800032-JLR200","article-title":"Mechanisms and consequences of macrophage apoptosis in atherosclerosis.","volume":"50","author":"T Seimon","year":"2009","journal-title":"J Lipid Res"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2174\/138945007783220623","article-title":"Apoptosis and efferocytosis in mouse models of atherosclerosis.","volume":"8","author":"I Tabas","year":"2007","journal-title":"Curr Drug Targets"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1189\/jlb.0209115","article-title":"Mechanisms and consequences of efferocytosis in advanced atherosclerosis.","volume":"86","author":"E Thorp","year":"2009","journal-title":"J Leukoc Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0030975","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T07:00:20Z","timestamp":1713596420000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0030975"}},"subtitle":[],"editor":[{"given":"Timothy W.","family":"Secomb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":78,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0030975","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}